About
Exact Sciences Corporation is a molecular diagnostics company with a strong focus on cancer care. Their mission is to eradicate cancer and the suffering it causes through tests that help prevent it, detect it earlier, and guide its successful treatment. They offer a comprehensive suite of tests for hereditary cancer screening, earlier cancer screenings, prognosis and treatment guidance, molecular residual disease (MRD) monitoring, and therapy selection.
The company’s flagship product, Cologuard, is the first FDA-approved stool DNA test for colorectal cancer detection. Exact Sciences is committed to rigorous science and revolutionary solutions, aiming to reduce cancer deaths significantly in the coming years by providing accurate and early detection.
Exact Sciences Medical Devices
1 – Cologuard®
Perhaps the most well-known product from Exact Sciences, Cologuard is a non-invasive, FDA-approved colorectal cancer screening test designed for individuals aged 45 and older at average risk for colorectal cancer. It analyzes stool DNA and blood markers to detect certain DNA mutations and blood components that could indicate the presence of colorectal cancer or its precursors. Its convenience and non-invasiveness have made it a popular choice for colorectal cancer screening.
2 – Oncotype DX®
This is a group of clinically validated genomic tests that analyze the genetics of a patient’s cancer to predict treatment benefits and outcomes. It’s particularly used in breast, colon, and prostate cancers, helping doctors and patients make more informed decisions about treatment, and potentially sparing patients from unnecessary chemotherapy.
Medical Device List
- Cologuard®
- Oncotype DX®
